Pluristem Therapeutics Inc.
(NASDAQ : PSTI)

( )
PSTI PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen Inc.
-0.24%343.281.2%$589.37m
GILDGilead Sciences, Inc.
1.33%73.320.9%$534.10m
CELGCelgene Corporation
0.35%91.201.2%$502.04m
AMGNAmgen Inc.
-0.13%197.311.2%$470.98m
ILMNIllumina, Inc.
1.67%331.443.5%$390.25m
REGNRegeneron Pharmaceuticals, Inc.
1.00%378.562.6%$309.76m
VRTXVertex Pharmaceuticals Incorporated
0.65%176.861.9%$202.70m
ALXNAlexion Pharmaceuticals, Inc.
0.71%116.992.0%$186.49m
AAgilent Technologies, Inc.
0.75%64.951.5%$163.20m
SRPTSarepta Therapeutics, Inc.
1.18%129.1416.6%$139.77m
NKTRNektar Therapeutics
2.24%61.965.6%$128.47m
EXASExact Sciences Corporation
1.71%50.0525.3%$122.85m
BLUEBluebird Bio, Inc.
0.06%158.8014.6%$120.19m
BMRNBioMarin Pharmaceutical Inc.
0.72%99.744.4%$119.07m
INCYIncyte Corporation
0.83%69.622.5%$116.18m

Company Profile

Pluristem Therapeutics, Inc. is a biotechnology company, which engages in the provision of cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The company focuses on cell therapies for the treatment of diseases such as muscle injury, acute radiation syndrome, pulmonary arterial hypertension and others. Its products include PLacental eXpanded, PLX-PAD, and PLX-R18. The company was founded by Doron Shorrer on May 11, 2001 and is headquartered in Haifa, Israel.